TDACU
Translational Development Acquisition Corp.
NASDAQ · Financial Services · Shell Companies · US
$11.60
−7.72%Price chart
Aug 17Aug 20Aug 25Aug 28Sep 2Sep 8Sep 11Sep 16
Key dataSep 16, 2026
Open$12.57
From 52W high−32.91%
Volume1.00
Market cap$305.15M
P/E (TTM)19.4x
P/S (TTM)—
Div yield—
Key dataSep 16, 2026
Open
$12.57
From 52W high
−32.91%
Volume
1.00
Market cap
$305.15M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−323.3x
P/E (TTM)
19.4x
RSI (14)
63.2
MomentumView details →
1D Return
−7.72%
YTD Return
+20.40%
Similar companies
Latest newsMore news →
ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.54d agoTranslational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.76d ago